National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  Allergic Diseases
  Clinical Infectious Diseases
  Cellular and Molecular Immunology
  Human Bacterial Pathogenesis
  Host Defenses
  Immunology
  Intracellular Parasites
  Infectious Diseases
  Immunogenetics
  Immunopathology
  Immunoregulation
  Molecular Immunology
  Molecular Microbiology
  Malaria and Vector Research
  Parasitic Diseases
  Persistent Viral Diseases
  Virology
   Tickborne Flavivirus Pathogenesis
  Viral Diseases
  Zoonotic Pathogens
  Malaria Vaccine Development
  Systems Immunology and Infectious Disease Modeling
  Research Technologies
  Vaccine Research
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Virology

Heinz Feldmann, M.D., Ph.D., Chief

The Laboratory of Virology conducts innovative scientific research on viral agents requiring high or maximum containment (Biosafety Level-2 to Biosafety Level-4). These agents include filoviruses, bunyaviruses, arenaviruses, and flaviviruses. Research studies focus on vector/reservoir transmission, viral ecology, pathogenesis, pathophysiology, and host immune response of these viral pathogens. A significant goal is to develop diagnostics, vaccines, and therapeutics against these agents.

LV scientists broadly study pathogens that cause viral hemorrhagic fevers, viral encephalitis, and certain respiratory diseases. This work employs investigations in cell culture; animal models, including nonhuman primates; reservoir species; and arthropod hosts in order to elucidate the viral pathogenesis, immune responses, molecular evolution, cellular and molecular biology, and vector-host interactions.

Goals

  1. Study pathogenesis and pathophysiology of high-containment viral pathogens using molecular technologies, including reverse genetics.
  2. Study immune responses to infection and vaccination of high-containment viral pathogens, and develop new vaccine candidates.
  3. Study vector/reservoir transmission of high-containment viral pathogens using appropriate animal models
  4. Use in vitro and in vivo systems to study the interactions between viral pathogens or viral components and host cells, and develop new antiviral strategies.
  5. Study the epidemiology and ecology of high-containment pathogens using newly developed rapid, sensitive, and specific diagnostic-test systems, including those that can be applied under field conditions.

Office of the Chief

Heinz Feldmann, M.D., Ph.D., Chief
Lesley W. Shupert, Ph.D., Biocontainment Suite Manager

Disease Modeling and Transmission Section

Heinz Feldmann, M.D., Ph.D., Chief

Tick-borne Flavivirus Pathogenesis Section

Marshall E. Bloom, M.D., Chief

back to top

Heinz Feldmann, M.D., Ph.D.

Contact Information

Heinz Feldmann, M.D., Ph.D.
Phone: 406-375-7410
E-mail: feldmannh@niaid.nih.gov

See Also

  • Division of Intramural Research (DIR)
  • Vaccine Research Center
  • Search in Labs at NIAID
     
    E-mail Icon E-mail this page
    Print Icon Print this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.
    Heinz Feldmann, M.D., Ph.D.

    Contact Information

    Heinz Feldmann, M.D., Ph.D.
    Phone: 406-375-7410
    E-mail: feldmannh@niaid.nih.gov

    See Also

  • Division of Intramural Research (DIR)
  • Vaccine Research Center